Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Roxane Carr"'
Publikováno v:
Paediatr Child Health
A Drug Access Navigator (DAN) is a role that has been established in patient care settings with the goal of expediting the process by which patients obtain drugs through the Health Canada Special Access Program (SAP), individual drug companies’ pat
Publikováno v:
The Journal of asthma : official journal of the Association for the Care of Asthma. 59(10)
Objective: The objective of this study was to assess the validity, feasibility and reliability of the Pediatric Asthma kNowleDge and mAnagement (PANDA) questionnaires that we developed.Methods: We developed 3 questionnaires aimed for Children, Teenag
Publikováno v:
Journal of pediatric hematology/oncology. 44(8)
High-dose methotrexate is part of the treatment of pediatric cancers. To reduce the risk of toxicity, supportive measures, including hydration and alkalinization, are recommended. At our institution, we switched from intravenous sodium bicarbonate to
Publikováno v:
Can J Hosp Pharm
Background: The relationship between a preceptor and a learner is complex and can be prone to conflict. The issue of conflict in experiential education has been studied in medicine, nursing, social work, and education; however, conflict between pharm
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 23:455-459
BACKGROUND Benzodiazepine and antipsychotic use for acute management of agitation and aggression in the pediatric emergency department (ED) setting has not been well described. OBJECTIVES To describe medication utilization in the management of agitat
Publikováno v:
Pediatric transplantation. 23(2)
MMF, a prodrug converted to the active form MPA, is an immunosuppressant used to prevent rejection in solid organ transplant recipients. MPA exposure, defined by AUC, can be estimated using limited sampling strategies (LSS). The relationship between
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
Background: Therapeutic drug monitoring (TDM) is helpful in situations where a drug has a narrow therapeutic index, a drug dosage does not reliably predict serum concentration, or a serum drug concentration has surrogate value (i.e., is reflective of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a791a5c63873ef994f84035193dda27
https://europepmc.org/articles/PMC6476573/
https://europepmc.org/articles/PMC6476573/
Publikováno v:
Clinical Therapeutics. 37:1897-1923
Purpose Clinicians are increasingly likely to have under their care obese children with diseases requiring pharmacotherapy. Optimal drug dosing for this population is unclear. Excess weight likely leads to alterations in pharmacokinetics. The purpose
Publikováno v:
Pediatric Drugs. 17:245-253
Pediatric studies and anecdotal experience suggest that current empiric vancomycin dosing does not reach serum trough concentration targets of at least 10 mg/L for uncomplicated infections or 15-20 mg/L for serious or complicated infections.This stud
Publikováno v:
Pediatric Drugs. 16:229-234
Intravenous acyclovir is the treatment of choice for herpes simplex virus encephalitis. In 2006, the American Academy of Pediatrics updated its dosing recommendations for children aged 3 months to 12 years to receive high-dose acyclovir (60 mg/kg/day